Phase 2 clinical trial to treat rare hereditary muscle disease shows promise
Monday, February 22, 2016 - 21:30
in Health & Medicine
Researchers present the first clinical study that provides evidence that an extended-release sialic acid supplement may stabilize muscle strength in patients with GNE myopathy (GNEM), a rare hereditary, progressive, adult-onset muscle disease.